✦ LIBER ✦

Adjuvant Aromatase Inhibitors Following Tamoxifen for Early-Stage Breast Cancer in Postmenopausal Women: What Do We Really Know?

✍ Scribed by Cathie T. Chung; Robert W. Carlson

Book ID: 115075660
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 115 KB
Volume: 5
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2004.s.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Choosing early adjuvant therapy for post

Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: Aromatase inhibitors versus tamoxifen

✍ R. Carpenter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

The role of aromatase inhibitors as adju

The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women

✍ Henning T. Mouridsen; Nicholas J. Robert 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Switching from tamoxifen to aromatase in

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer

✍ C.J.H. van de Velde; S. Verma; J.G.H. van Nes; C. Masterman; K.I. Pritchard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Aromatase inhibitor-induced arthralgia i

Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?

✍ Omar S. Din; David Dodwell; Richard J. Wakefield; Robert E. Coleman 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 260 KB

PCN69 Cost-Effectiveness Analysis of Aro

PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

✍ Sura, S.D.; Sansgiry, S.S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Do adjuvant aromatase inhibitors increas

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version